About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Antioxidant Effects for Alzheimer's Disease on Cerebrospinal Fluid Biomarkers Examined

by Kathy Jones on March 22, 2012 at 7:27 PM
Font : A-A+

 Antioxidant Effects for Alzheimer's Disease on Cerebrospinal Fluid Biomarkers Examined

A randomized trial has found that an antioxidant combination of vitamin E, vitamin C and alpha-lipoic acid (E/C/ALA) was not associated with changes in some cerebrospinal fluid biomarkers related to Alzheimer disease. The study is published Online First by Archives of Neurology, one of the JAMA/Archives journals.

Oxidative damage in the brain is associated with aging and is widespread in Alzheimer disease (AD) patients. Some observational studies have suggested that an antioxidant-rich diet may reduce the risk of AD, but antioxidant randomized clinical trials in AD have had mixed results, the authors write in their study background.

Advertisement

Douglas R. Galasko, M.D., of the University of California, San Diego, and colleagues examined changes in cerebrospinal fluid (CSF) biomarkers related to Alzheimer disease and oxidative stress, cognition and function.

The study included 78 patients from the Alzheimer's Disease Cooperative Study (ADCS) Antioxidant Biomarker study who were divided into one of three groups: 800 IU/per day of vitamin E (α-tocopherol) plus 500 mg/per day of vitamin C plus 900 mg/per day of α-lipoic acid (E/C/ALA); 400 mg of coenzyme Q (CoQ) three times a day; or placebo. Sixty-six patients provided serial CSF specimens adequate for biochemical analyses during the 16-week trial.
Advertisement

"The combination of E/C/ALA did not affect CSF biomarkers related to Αβ, tau or P-tau (which are related to AD)," the authors comment.

The E/C/ALA group did see a lowering of CSF F2-isoprostane levels suggesting a reduction of oxidative stress in the brain, the results indicate. However, the treatment raised caution about faster cognitive decline as assessed by the Mini-Mental State Examination (MMSE).

"It is unclear whether the relatively small reduction in CSF F2-isoprostane level seen in this study may lead to clinical benefits in AD. The more rapid MMSE score decline raises a caution and indicates that cognitive performance would need to be assessed if a longer-term clinical trial of this antioxidant combination is considered," the authors conclude.

The authors also note the results indicate that while CoQ was safe and well tolerated in patients, the absence of a biomarker signal in CSF suggests that CoQ, at the tested dose, does not improve indices of oxidative stress or neurodegeneration.

"These results do not support further clinical trial development of CoQ in AD," the researchers conclude.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Alzheimers Disease Otitis Media Ganglion Cysts - Ganglion Wrist Food Additives Herbs and Antioxidants Mint It All! Quiz on Antioxidants Foods that Gives You Sparkling Eyes Berries for a Healthy and Beautiful You Anti-Aging Treatment with Vinotherapy or Wine Facials 

Most Popular on Medindia

Drug Interaction Checker Post-Nasal Drip Pregnancy Confirmation Calculator Find a Hospital Iron Intake Calculator Turmeric Powder - Health Benefits, Uses & Side Effects Sinopril (2mg) (Lacidipine) Hearing Loss Calculator Nutam (400mg) (Piracetam) Blood Pressure Calculator
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Antioxidant Effects for Alzheimer's Disease on Cerebrospinal Fluid Biomarkers Examined Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests